{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:35:32Z","timestamp":1782506132460,"version":"3.54.5"},"reference-count":48,"publisher":"Bentham Science Publishers Ltd.","issue":"4","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"funder":[{"DOI":"10.13039\/100013142","name":"Weill Cornell Medical College Clinical; Translational Science Center CTSC","doi-asserted-by":"publisher","award":["UL1TR000457"],"award-info":[{"award-number":["UL1TR000457"]}],"id":[{"id":"10.13039\/100013142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAS"],"published-print":{"date-parts":[[2019,4,22]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Prodromal Neurodegenerative Disease (ND) due to tauopathies such as\nAlzheimer\u2019s Disease (AD) and Synucleinopathies (SN) such as Parkinson's Disease (PD) and Dementia\nwith Lewy Bodies (DLB) present subtly. Although ND are considered cognitive disorders, in\nfact ND present with behavioral and even medical symptomatology years to decades prior to the\nonset of cognitive changes. Recognizing prodromal ND syndromes is a public health priority because\nND is common, disabling and expensive. Diagnosing prodromal ND in real world clinical\nsettings is challenging because ND of the same pathology can present with different symptoms in\ndifferent people. Individual variability in nature and variability in nurture across the life course influence\nhow ND pathology manifests clinically. The objective of this study was to describe how\nnon-cognitive symptoms from behavioral, medical, neurological and psychiatric domains cluster in\nprodromal and early stages of ND.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This was an observational study of patients receiving routine clinical care for memory\ndisorders. All patients receiving a standardized evaluation including complete neurological history\nand examination and standardized brief neuropsychological testing. A Principal Component Analysis\n(PCA) considering emotion, motor, sensory and sleep factors was performed on the entire sample of\npatients in order to identify co-occurring symptom clusters. All patients received a consensus diagnosis\nadjudicated by at least two dementia experts. Patients were grouped into Cognitively Normal, Detectable\nCognitive Impairment, and Mild Cognitive Impairment categories due to AD and\/or PD\/LBD or\nNOS pathology. Symptom cluster scores were compared between clinical diagnostic groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In this study 165 patients completed baseline neuropsychological testing and reported subjective\nmeasures of non-cognitive symptoms. Four syndrome specific symptom factors emerged\nand eight non-specific symptom factors. Symptoms of personality changes, paranoia, hallucinations,\ncravings, agitation, and changes in appetite grouped together into a cluster consistent with an \"SN\nNon-motor Phenotype\". Appetite, walking, balance, hearing, increased falls, and dandruff grouped\ntogether into a cluster consistent with an \"SN Motor Phenotype\". The Prodromal AD phenotype included\nsymptoms of anxiety, irritability, apathy, sleep disturbance and social isolation. The fourth\nfactor included symptoms of increased sweating, twitching, and tremor grouped into a cluster consistent\nwith an Autonomic phenotype.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Non-cognitive features can be reliably measured by self-report in busy clinical settings.\nSuch measurement can be useful in distinguishing patients with different etiologies of ND.\nBetter characterization of unique, prodromal, non-cognitive ND trajectories could improve public\nhealth efforts to modify the course of ND for all patients at risk.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874609812666190204094233","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T06:56:32Z","timestamp":1549263392000},"page":"242-249","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases"],"prefix":"10.2174","volume":"11","author":[{"given":"Alon","family":"Seifan","sequence":"first","affiliation":[{"name":"Neuro Well Free, Medicine, Fort Lauderdale, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Ganzer","sequence":"additional","affiliation":[{"name":"Hunter College, Nursing, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Ryon","sequence":"additional","affiliation":[{"name":"Nova Southeastern, Medicine, Fort Lauderdale, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lin","sequence":"additional","affiliation":[{"name":"Nova Southeastern, Medicine, Fort Lauderdale, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman","family":"Mahmudur","sequence":"additional","affiliation":[{"name":"Neuro Well Free, Medicine, Fort Lauderdale, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriquez","family":"Adolfo","sequence":"additional","affiliation":[{"name":"Neuro Well Free, Medicine, Fort Lauderdale, Florida, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Shih","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Cornell Medicine, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Private Practice, Medicine, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Greenwald","sequence":"additional","affiliation":[{"name":"Private Practice, Medicine, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Isaacson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Weill Cornell Medicine, New York, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaneurol.2016.2642","volume":"73","author":"Gordon B.A.","year":"2016","unstructured":"Gordon BA, Blazey T, Su Y.  Longitudinal beta-amyloid deposition and hippocampal volume in preclinical alzheimer disease and suspected non-alzheimer disease pathophysiology.","journal-title":"JAMA Neurol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1017\/S1041610211001220","volume":"23","author":"Frisoni G.B.","year":"2011","unstructured":"Frisoni GB, Winblad B, O\u2019Brien JT.  Revised NIA-AA criteria for the diagnosis of Alzheimer\u2019s disease: A step forward but not yet ready for widespread clinical use.","journal-title":"Int Psychogeriatr"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3233\/JAD-160326","volume":"53","author":"Krell-Roesch J.","year":"2016","unstructured":"Krell-Roesch J, Ruider H, Lowe VJ.  FDG-PET and neuropsychiatric symptoms among cognitively normal elderly persons: The mayo clinic study of aging.","journal-title":"J Alzheimers Dis"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1017\/S1041610216000405","volume":"28","author":"Burke S.L.","year":"2016","unstructured":"Burke SL, Maramaldi P, Cadet T.  Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer\u2019s disease: Dementia.","journal-title":"Int Psychogeriatr"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaneurol.2013.2334","volume":"70","author":"Ju Y.E.","year":"2013","unstructured":"Ju YE, McLeland JS, Toedebusch CD.  Sleep quality and preclinical Alzheimer disease.","journal-title":"JAMA Neurol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neurol.2016.07.001","volume":"172","author":"Elbaz A.","year":"2016","unstructured":"Elbaz A.  Prodromal symptoms of Parkinson\u2019s disease: Implications for epidemiological studies of disease etiology.","journal-title":"Rev Neurol (Paris)"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archgenpsychiatry.2011.1481","volume":"69","author":"Barnes D.E.","year":"2012","unstructured":"Barnes DE, Yaffe K, Byers AL.  Midlife  late-life depressive symptoms and risk of dementia: Differential effects for Alzheimer disease and vascular dementia.","journal-title":"Arch Gen Psychiatry"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"Postuma R.","year":"2015","unstructured":"Postuma R, Daniela B, Matthew S.  MDS clinical diagnostic criteria for Parkinson\u2019s disease.","journal-title":"Mov Disord"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000339363","volume":"33","author":"Chiba Y.","year":"2012","unstructured":"Chiba Y, Fujishiro H, Iseki E.  Retrospective survey of prodromal symptoms in dementia with Lewy bodies: Comparison with Alzheimer\u2019s disease.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jagp.2016.04.004","volume":"24","author":"Ganesh M.B.","year":"2016","unstructured":"Ganesh MB, Nupur G, Denise H.  Mood changes in cognitively normal older adults are linked to Alzheimer disease biomarker levels.","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"Postuma R.B.","year":"2012","unstructured":"Postuma RB, Aarsland D, Barone P.  Identifying prodromal Parkinson\u2019s disease: Pre-motor disorders in Parkinson\u2019s disease.","journal-title":"Mov Disord"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","volume":"90","author":"Petersen R.C.","year":"2018","unstructured":"Petersen RC, Lopez O, Armstrong MJ.  Practice guideline update summary: Mild cognitive impairment: Report of the guideline development, dissemination, and implementation subcommittee of the american academy of neurology.","journal-title":"Neurology"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1474-4422(05)70286-6","volume":"5","author":"Whalley L.J.","year":"2006","unstructured":"Whalley LJ, Dick FD, McNeill G.  A life-course approach to the aetiology of late-onset dementias.","journal-title":"Lancet Neurol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","volume":"12","author":"Ismail Z.","year":"2016","unstructured":"Ismail Z, Smith EE, Geda Y.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.","journal-title":"Alzheimers Dement"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/nedt.2007.3.1.145","volume":"3","author":"Clelia P.","year":"2007","unstructured":"Clelia P, Dario B, Vincenzo P.  Prodromal non-motor symptoms of Parkinson\u2019s disease.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","volume":"14","author":"Schrag A.","year":"2015","unstructured":"Schrag A, Horsfall L, Walters K.  Prediagnostic presentations of Parkinson\u2019s disease in primary care: A case-control study.","journal-title":"Lancet Neurol"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3233\/JAD-141134","volume":"43","author":"Takizawa C.","year":"2015","unstructured":"Takizawa C, Thompson PL, van Walsem A.  Epidemiological and economic burden of Alzheimer\u2019s disease: A systematic literature review of data across Europe and the United States of America.","journal-title":"J Alzheimers Dis"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mam.2015.06.005","volume":"43-44","author":"Snyder H.M.","year":"2015","unstructured":"Snyder HM, Hendrix J, Bain LJ.  Alzheimer\u2019s disease research in the context of the national plan to address Alzheimer\u2019s disease.","journal-title":"Mol Aspects Med"},{"key":"ref=19","first-page":"1015","volume":"1","author":"Broderick J.E.","year":"2013","unstructured":"Broderick JE, DeWitt EM, Rothrock N.  Advances in Patient-Reported Outcomes: The NIH PROMIS((R)) Measures.","journal-title":"EGEMS (Wash DC)"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/ALN.0b013e31816d91b5","volume":"108","author":"Chung F.","year":"2008","unstructured":"Chung F, Yegneswaran B, Liao P.  Validation of the Berlin questionnaire and American Society of Anesthesiologists checklist as screening tools for obstructive sleep apnea in surgical patients.","journal-title":"J Am Soc Anesthesiol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/gps.4049","volume":"29","author":"Ezzati A.","year":"2014","unstructured":"Ezzati A, Jiang J, Katz MJ.  Validation of the perceived stress scale in a community sample of older adults.","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","volume":"190","author":"Zhao Q.F.","year":"2016","unstructured":"Zhao QF, Tan L, Wang HF.  The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: Systematic review and meta-analysis.","journal-title":"J Affect Disord"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1468-1331.2010.03064.x","volume":"18","author":"Golimstok A.","year":"2011","unstructured":"Golimstok A, Rojas J, Romano M.  Previous adult attention-deficit and hyperactivity disorder symptoms and risk of dementia with Lewy bodies: A case-control study.","journal-title":"Eur J Neurol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.14802\/jmd.15003","volume":"8","author":"Lee H.M.","year":"2015","unstructured":"Lee HM, Koh SB.  Many Faces of Parkinson\u2019s disease: Non-motor symptoms of Parkinson\u2019s disease.","journal-title":"J Mov Disord"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"e0129919","DOI":"10.1371\/journal.pone.0129919","volume":"10","author":"Seifan A.","year":"2015","unstructured":"Seifan A, Assuras S, Huey ED.  Childhood learning disabilities and atypical dementia: A retrospective chart review.","journal-title":"PLoS One"},{"key":"ref=26","first-page":"689","volume":"24","author":"Cockrell J.","year":"1988","unstructured":"Cockrell J, Folstein M.  Mini-Mental State Examination (MMSE).","journal-title":"Psychopharmacol Bull"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/geronj\/47.3.P154","volume":"47","author":"Mack W.J.","year":"1992","unstructured":"Mack WJ, Freed DM, Williams BW.  Boston Naming Test: shortened versions for use in Alzheimer\u2019s disease.","journal-title":"J Gerontol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","volume":"19","author":"Tombaugh T.N.","year":"2004","unstructured":"Tombaugh TN.  Trail Making Test A and B: Normative data stratified by age and education.","journal-title":"Arch Clin Neuropsychol"},{"key":"ref=29","author":"Schmidt M.","year":"","unstructured":"Schmidt M.","journal-title":"Rey auditory verbal learning test: A handbook 1996:\nWestern Psychological Services Los Angeles, CA"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/S1355617714000320","volume":"20","author":"Weintraub S.","year":"2014","unstructured":"Weintraub S, Dikmen SS, Heaton RK.  The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: Validation in an adult sample.","journal-title":"J Int Neuropsychol Soc"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"McKeith I.G.","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium.","journal-title":"Neurology"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"Alberta M.S.","year":"2011","unstructured":"Alberta MS, Steven TD, Dennis D.  The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","journal-title":"Alzheimers Dement"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"McKhann G.M.","year":"2011","unstructured":"McKhann GM, David SK, Howard C.  The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","journal-title":"Alzheimers Dement"},{"key":"ref=34","author":"","year":"Gomperts SN. Lewy body dementias: Dementia with lewy bodies\nand parkinson disease dementia. Continuum (Minneap Minn),\n2016. 22(2 Dementia): p. 435-63","unstructured":"."},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.parkreldis.2014.10.020","volume":"21","author":"Szeto J.Y.","year":"2015","unstructured":"Szeto JY, Mowszowski L, Gilat M.  Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease.","journal-title":"Parkinsonism Relat Disord"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000439568","volume":"45","author":"Seifan A.","year":"2015","unstructured":"Seifan A, Schelke M, Obeng-Aduasare Y.  Early life epidemiology of Alzheimer\u2019s disease-a critical review.","journal-title":"Neuroepidemiology"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00702-016-1622-6","volume":"123","author":"Maria T.P.","year":"2016","unstructured":"Maria TP, Riccardo S, Marcello M.  Lower serum uric acid is associated with mild cognitive impairment in early Parkinson\u2019s disease: A 4-year follow-up study.","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/mds.26662","volume":"31","author":"Delgado\u2010Alvarado M.","year":"2016","unstructured":"Delgado\u2010Alvarado M, Bel\u00e9n G, Navalpotro\u2010Gomez I.  Biomarkers for dementia and mild cognitive impairment in Parkinson\u2019s disease.","journal-title":"Mov Disord"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.0000000000001238","volume":"84","author":"Masters M.C.","year":"2015","unstructured":"Masters MC, Morris JC, Roe CM.  \u201cNoncognitive\u201d symptoms of early Alzheimer disease: A longitudinal analysis.","journal-title":"Neurology"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","volume":"75","author":"Claassen D.O.","year":"2010","unstructured":"Claassen DO, Josephs KA, Ahlskog JE.  REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.","journal-title":"Neurology"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-150181","volume":"49","author":"Bensamoun D.","year":"2015","unstructured":"Bensamoun D.  Associations between neuropsychiatric symptoms and cerebral amyloid deposition in cognitively impaired elderly people.","journal-title":"J Alzheimers Dis"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.0000000000000960","volume":"83","author":"Danna J.","year":"2014","unstructured":"Danna J, Andrew S, Matthew S.  Imaging prodromal Parkinson disease: The parkinson associated risk syndrome study.","journal-title":"Neurology"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jalz.2014.03.005","volume":"11","author":"Edmonds E.C.","year":"2015","unstructured":"Edmonds EC, Delano-Wood L, Clark LR.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.","journal-title":"Alzheimers Dement"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3233\/JAD-150986","volume":"52","author":"Edmonds E.C.","year":"2016","unstructured":"Edmonds EC, Delano-Wood L, Jak AJ.  \u201cMissed\u201d mild cognitive impairment: High false-negative error rate based on conventional diagnostic criteria.","journal-title":"J Alzheimers Dis"},{"key":"ref=45","first-page":"254","volume":"2","author":"Seifan A.","year":"2015","unstructured":"Seifan A, Isaacson RI.  The Alzheimer\u2019s prevention clinic at weill cornell medicine: Risk stratification and early intervention.","journal-title":"J Prev Alzheimers Dis"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.025","volume":"44","author":"Vos S.J.B.","year":"2016","unstructured":"Vos SJB, Gordon BA, Su Y.  NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers.","journal-title":"Neurobiol Aging"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"Tiia N.","year":"2015","unstructured":"Tiia N, Jenni L, Alina S.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial.","journal-title":"Lancet"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"Sevigny J.","year":"2016","unstructured":"Sevigny J.  The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease.","journal-title":"Nature"}],"container-title":["Current Aging Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T03:32:17Z","timestamp":1559100737000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169580\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,22]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874609812666190204094233","relation":{},"ISSN":["1874-6098"],"issn-type":[{"value":"1874-6098","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}